STAT3 and neoplasm: Although studies have extensively examined the molecular pathways involved in the STAT3 regulation in GC, and how anti-tumor compounds can be beneficial in suppressing STAT3 in GC therapy, there are a number of drawbacks that should be considered in further studies.